导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 5.03% | 376/1050 |
| 近一周 | -1.57% | 246/1104 |
| 近一月 | -1.80% | 200/1102 |
| 近一季 | -5.94% | 464/1092 |
| 近半年 | 4.01% | 339/1070 |
| 近一年 | 9.11% | 366/1018 |
| 近两年 | 57.74% | 447/926 |
| 近三年 | 43.26% | 301/834 |
| 成立以来 | 88.23% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.40% 676/1070 |
19.05% 396/1101 |
- - |
- - |
| 2025 | 22.76% 619/1065 |
0.26% 782/1014 |
3.89% 368/1038 |
15.92% 729/1050 |
1.66% 334/1065 |
| 2024 | 16.35% 145/1011 |
2.42% 194/960 |
0.29% 287/983 |
14.04% 299/991 |
-0.67% 359/1011 |
| 2023 | -6.85% 247/952 |
3.73% 391/880 |
-2.34% 327/895 |
-3.15% 211/915 |
-5.06% 512/952 |
| 2022 | -22.87% 433/867 |
-13.46% 195/773 |
6.20% 452/806 |
-11.99% 389/845 |
-4.64% 631/867 |
| 2021 | 5.16% 301/740 |
-2.68% 248/580 |
9.33% 377/659 |
-1.70% 248/704 |
0.54% 418/740 |
| 2020 | 47.11% 254/554 |
-5.83% 311/419 |
20.20% 283/466 |
16.02% 131/517 |
12.02% 294/554 |
| 2019 | - - |
- - |
- - |
1.10% 304/390 |
9.38% 180/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 博道叁佰智航股票C VS. 东吴新产业精选股票A(580008) |